Loading...
GDNF is not required for catecholaminergic neuron survival in vivo
Glial cell line-derived neurotrophic factor (GDNF) has been tested in clinical trials to treat Parkinson’s disease with promising but variable results. Improvement of therapeutic effectiveness requires solid understanding of the physiological role of GDNF in the maintenance of the adult brain catech...
Na minha lista:
| Udgivet i: | Nat Neurosci |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4878654/ https://ncbi.nlm.nih.gov/pubmed/25710828 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nn.3941 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|